Tate Simon 4
4 · Eliem Therapeutics, Inc. · Filed Aug 11, 2021
Insider Transaction Report
Form 4
Tate Simon
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-08-09+20,000→ 20,000 totalExercise: $12.50Exp: 2031-08-08→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/36th of the shares will vest on each monthly anniversary of August 1, 2021.